These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4447919)

  • 41. Cortical audiometry: an objective method of evaluating auditory acuity in awake and sleeping man.
    Cody DT; Klass DW; Bickford RG
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(1):81-91. PubMed ID: 6050313
    [No Abstract]   [Full Text] [Related]  

  • 42. [Toxic effects of cisplatin in the treatment of malignant bone and soft tissue tumors].
    Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1857-61. PubMed ID: 3707148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ototoxicity of cisplatin in children with malignant diseases].
    Hadjilaskari P; Fengler R; Hartmann R; Henze G
    Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Research on the ACTH-induced variations in blood iron in relation to the uric acid and creatinine content and the eosinophil count of the blood].
    INDOVINA I; SAVAGNONE E; INDOVINA T
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):775-8. PubMed ID: 13106045
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of utilising patient self-report of auditory complaints to monitor aminoglycoside ototoxicity.
    Ramma LD; Ibekwe TS
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):283. PubMed ID: 22236938
    [No Abstract]   [Full Text] [Related]  

  • 46. Ototoxicity of cis-diamminedichloroplatinum.
    Vodvárka P; Foukalová J; Mrázek J; Philippová J
    Neoplasma; 1985; 32(2):229-38. PubMed ID: 4039797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Delayed platinum diamminodichloride toxicity in patients with germ tumors of the gonads].
    Germà Lluch JR; Izquierdo Font A; Barnadas Molins A; Arcusa Lanza MA; Ojeda González B
    Med Clin (Barc); 1984 Mar; 82(10):442-5. PubMed ID: 6538917
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
    Piel IJ; Perlia CP
    Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies of auditory ability of hard-of-hearing patients. Part II: The relationship between self-rating and the results of audiometry (author's transl)].
    Yamamoto K
    Nihon Jibiinkoka Gakkai Kaiho; 1976 Nov; 79(11):1357-67. PubMed ID: 1034679
    [No Abstract]   [Full Text] [Related]  

  • 50. [Secondary gout, 6 years after acute renal failure].
    Mertz DP; Schindera F
    Dtsch Med Wochenschr; 1968 May; 93(18):908-12 passim. PubMed ID: 5655007
    [No Abstract]   [Full Text] [Related]  

  • 51. Phase I study of twice weekly 5-azacytidine (NSC-102816).
    Vogler WR; Arkun S; Velez-Garcia E
    Cancer Chemother Rep; 1974; 58(6):895-9. PubMed ID: 4141280
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical evaluation of hexamethylmelamine (NSC-13875).
    Bergevin PR; Tormey DC; Blom J
    Cancer Chemother Rep; 1973 Feb; 57(1):51-8. PubMed ID: 4704103
    [No Abstract]   [Full Text] [Related]  

  • 53. Low platelet counts in Zambians.
    Gill GV; England A; Marshal C
    Trans R Soc Trop Med Hyg; 1979; 73(1):111-2. PubMed ID: 442169
    [No Abstract]   [Full Text] [Related]  

  • 54. Hydroxyurea: a new antimetabolite in the treatment of psoriasis.
    Rosten M
    Br J Dermatol; 1971 Aug; 85(2):177-81. PubMed ID: 5571034
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment-related ototoxicity.
    Walker DA; Waters KD
    J Clin Oncol; 1990 Jan; 8(1):179-80. PubMed ID: 2295908
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges of Hearing Rehabilitation after Radiation and Chemotherapy.
    Nader ME; Gidley PW
    J Neurol Surg B Skull Base; 2019 Apr; 80(2):214-224. PubMed ID: 30931231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD009219. PubMed ID: 27669661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisplatin exposure damages resident stem cells of the mammalian inner ear.
    Slattery EL; Oshima K; Heller S; Warchol ME
    Dev Dyn; 2014 Oct; 243(10):1328-37. PubMed ID: 24888499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the effects of chemotherapy on auditory function.
    Dutta A; Venkatesh MD; Kashyap RC
    Indian J Otolaryngol Head Neck Surg; 2005 Jul; 57(3):226-8. PubMed ID: 23120177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.